Insight Molecular Diagnostics Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Insight Molecular Diagnostics Inc. stock issued during period, value, new issues for the quarter ending 2024-12-31 was $1.64M.
- Insight Molecular Diagnostics Inc. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $17.00K.
- Insight Molecular Diagnostics Inc. stock issued during period, value, new issues for the quarter ending 2022-12-31 was $0.00.
- Insight Molecular Diagnostics Inc. stock issued during period, value, new issues for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- Insight Molecular Diagnostics Inc. stock issued during period, value, new issues for fiscal 2024 was $1.66M.
- Insight Molecular Diagnostics Inc. stock issued during period, value, new issues for fiscal 2022 was $32.45M.
- Insight Molecular Diagnostics Inc. stock issued during period, value, new issues for fiscal 2020 was $18.34M, a 62.45% decline from fiscal 2019.
- Insight Molecular Diagnostics Inc. stock issued during period, value, new issues for fiscal 2019 was $48.85M, a 259.40% increase from fiscal 2018.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $1.66M 10-K · filed 2026-03-26 |
| 2024-09-30 | $17.00K 10-Q · filed 2025-11-10 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $32.45M 10-K · filed 2024-04-16 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | |
| 2022-06-30 | $32.42M 10-Q · filed 2023-08-10 | |
| 2021-09-30 | $6.24M 10-Q · filed 2021-11-09 | |
| 2021-03-31 | $71.75M 10-Q · filed 2021-05-17 | $82.49M derived: sum of 4 quarters · filed 2022-03-11 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $18.34M 10-K · filed 2022-03-11 |
| 2020-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $26.94M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $10.75M 10-Q · filed 2021-08-11 | $26.94M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $7.60M 10-Q · filed 2021-05-17 | $14.20M derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $8.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | $48.85M 10-K · filed 2021-03-19 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $43.84M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $43.84M derived: sum of 4 quarters · filed 2020-07-29 |
| 2019-03-31 | $42.25M 10-Q · filed 2020-05-12 | $47.84M derived: sum of 4 quarters · filed 2020-05-12 |
| 2018-12-31 | $3.59M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $13.59M 10-K · filed 2020-03-26 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | |
| 2018-06-30 | $2.00M 10-Q · filed 2019-08-14 | |
| 2018-03-31 | $8.00M 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |